Form D · Biotechnology
PROMETHEON PHARMA, LLC
Gainesville, FL · CIK 0001588339
Offering snapshot reported Apr 18, 2016 · SEC filing
- Reported sold
- Yet to sell Offering amount: $2M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 18, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 15, 2016 | Amendment | $1,132,754 | $532,754vs Mar 27, 2014 | 15 | SEC filing |
| Mar 27, 2014 | Amendment | $600,000 | No comparison | 10 | SEC filing |
| Oct 4, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-261538
Offering of unsecured convertible promissory notes.
Source: Form D, filed Apr 18, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen I. Hsu | Director, Executive |
| Stephen I. Hsu Md Ph D | Director, Executive |
| Roger Mazze | Director |
| Roger S. Mazze Ph D | Director |
| Richard Miles | Director |
| Richard Miles Ba M Sc | Director |
| Frank Silver | Director |
| Frank M. Silver Ph D | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3005 Sw 70 Th Lane
Gainesville, FL, 32608
Gainesville, FL, 32608